Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Genmab (GMAB)

  • Business News
  • Dec. 12, 2025, 06:36 UTC
  • 1
  • 1 comments

Genmab Announces Completion of Tender Offer for Outstanding Common Shares of Merus N.V. and Commencement of Subsequent Offering Period

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Dec. 12, 2025, 06:14 UTC
  • 1
  • 1 comments

Latest About iPod Nano 7th Generation

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Dec. 12, 2025, 06:12 UTC
  • 1
  • 1 comments

Shark FlexStyle vs Dyson Airwrap

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Dec. 12, 2025, 06:08 UTC
  • 1
  • 1 comments

Latest About Motorola One 5G Ace

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Dec. 12, 2025, 06:07 UTC
  • 1
  • 1 comments

Latest About iPhone 13 Mini (2026 Guide)

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Dec. 12, 2025, 06:04 UTC
  • 1
  • 1 comments

The Best Handheld Game Consoles For 2026: Ultimate Buying Guide

Market reaction Comment Full text

Tenaya Therapeutics Inc (TNYA)

  • Business News
  • Dec. 12, 2025, 05:16 UTC
  • 2
  • 1 comments

Tenaya Therapeutics Announces Pricing of Public Offering

Market reaction Comment Full text

Rezolute Inc. (RZLT)

  • Business News
  • Dec. 12, 2025, 00:59 UTC
  • 1
  • 1 comments

Hagens Berman Investigating Rezolute, Inc. (RZLT) as Shares Tank 90% Amid Lead Asset Trial Failure

Market reaction Comment Full text

Integer Holdings Corp (ITGR)

  • Business News
  • Dec. 12, 2025, 00:47 UTC
  • 1
  • 1 comments

Investor Notice: Robbins LLP Informs Investors of the Integer Holdings Corporation Securities Class Action

Market reaction Comment Full text

Integer Holdings Corp (ITGR)

  • Business News
  • Dec. 11, 2025, 23:56 UTC
  • 1
  • 1 comments

Integer Holdings Corporation Securities Fraud Class Action Result of Undisclosed Financial Problems and 32% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Market reaction Comment Full text
  • 1
  • 2
  • 3
  • Next

Search

News categories

  • Technical Exchange News(10560)
  • Event(1902)
  • SEC News(183041)
  • FDA Approval(9787)
  • Company Report(721)
  • Business News(121443)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin